greeksoup/ stock research

Omega Healthcare Investors (OHI) FY2022 results: revenue $878 million, down 17.4% on the year

Omega Healthcare Investors Inc. (OHI) reported revenue of $878 million for fiscal 2022, the year ended 31 December 2022, down 17.4% on the year before. Net income was $427 million, up 2.4%, and diluted earnings per share $1.80. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2023.

Revenue
$878 million
-17.4% on the year
FY2015FY2022
Operating margin
8.9%
26.9% a year earlier
FY2015FY2022
Net income
$427 million
+2.4% on the year
FY2015FY2022
Diluted EPS
$1.80
+2.9% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue8781,063892-17.4%
Operating income78.6286157-72.5%
Operating margin8.9%26.9%17.6%
Interest expense233235223-0.6%
Pre-tax income436416162+4.8%
Income tax4.63.84.9+18.8%
Effective tax rate1.0%0.9%3.0%
Net income427417159+2.4%
Net margin48.6%39.2%17.9%
Diluted EPS$1.80$1.75$0.70+2.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow626722708-13.4%
Capital expenditure47.244.931.1+5.1%
Free cash flow579677677-14.6%
Free cash flow margin65.9%63.7%75.9%
Cash from investing443-524-89.1
Cash from financing-789-341-486
Depreciation and amortisation332342330-2.8%
Share-based compensation27.321.418.8+27.5%
Buybacks142n/an/a
Dividends paid633638612-0.7%
Dividend per share$2.68$2.68$2.680.0%
Diluted shares, weighted244m244m235m-0.0%
Shares outstanding at period end234m239m231m-2.0%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity3,6093,9073,842-7.6%
Non-controlling interest194201195-3.7%
Debt5,2875,2545,169+0.6%
Other liabilities315277292+13.9%
Total liabilities and equity9,4059,6389,497-2.4%
Goodwill643651652-1.3%
Intangible assets1.41.61.9-10.6%
Loans1,043n/an/a
Cash and equivalents29720.5164+1,346.9%
Other assets7,4218,9658,680-17.2%
Total assets9,4059,6389,497-2.4%

10-K for the year ended 31 December 2022, filed 14 February 2023: the filing.